DUSP3 and lung carcinoma: This result was further validated by immunohistochemistry (IHC) analysis of DUSP3 protein expression in human lung cancer tissues from Cohort 2 TMA, which included well-differentiated, moderately differentiated, and poorly differentiated lung tumors.